The retail clinic market is expected to be valued at US$ 5,659.2 million in 2024 and reach US$ 12,308.7 million by 2034. The market is projected to grow at a CAGR of 8.1% during the forecast period.
Key Market Drivers
Attributes | Key Statistics |
---|---|
Retail Clinic Market Value (2024) | US$ 5,659.2 million |
Anticipated Market Value (2034) | US$ 12,308.7 million |
Value-based CAGR (2024 to 2034) | 8.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The retail clinic market is experiencing substantial growth driven by increasing demand for convenient and accessible healthcare options.
The retail clinic market is anticipated to surpass a valuation of US$ 12,308.7 million by 2034, expanding at an 8.1% CAGR over the forecast period. While the retail clinics market is experiencing growth, several restraining factors can adversely affect its development and expansion:
The section deals with two other markets that have the potential to give rigorous competition to the retail clinic market. These markets are the outpatient clinic market and the mobile clinic market. The respective markets' growth factors and critical challenges are also discussed below in the tables. Retail Clinic Market
Retail Clinic Market:
Attributes | Retail Clinic Market |
---|---|
CAGR (2024 to 2034) | 8.1% |
Growth Factor |
|
Key Challenges |
|
Outpatient Clinic Market:
Attributes | Outpatient Clinic Market |
---|---|
CAGR (2023 to 2033) | 4.2% |
Growth Factor |
|
Key Challenges | Reimbursement Issues and Regulatory Compliance |
Mobile Clinic Market:
Attributes | Mobile Clinic Market |
---|---|
CAGR (2022 to 2032) | 11.3% |
Growth Factor | Access populations in remote, difficult areas, as well as groups, cut off from mainstream medical care due to geography and climatic factors |
Key Challenges | Maintaining continuity of care |
Attributes | Details |
---|---|
Ownership Type | Retail-owned |
Market Share in 2024 | 58.6% |
Based on the ownership type, the retail-owned segment dominates the market with a share of 58.6% in 2024. The segment’s rising popularity is attributed to the following factors:
Attributes | Details |
---|---|
Distribution Channel | Drug Store |
Market Share | 52.0% |
Based on the distribution channel, drug stores dominate the market by distribution channel, holding a share of 52.0%. This rising popularity of the segment is attributed to the following reasons:
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The section analyzes the retail clinic market by country, including the United States, China, Germany, France, and Japan. The table presents the CAGRs for each country, indicating the expected market growth in that country through 2034.
Countries | CAGR (2024 to 2034) |
---|---|
United States | 10.9% |
China | 11.4% |
Germany | 10.6% |
France | 10.2% |
Japan | 10.3% |
China is a leading Asian country in the retail clinic market. The Chinese market is anticipated to register a CAGR of 13.6% through 2034.
The United States dominates the retail clinic market in the North American region. The United States retail clinic market is anticipated to exhibit a CAGR of 10.9% through 2034.
In the European region, Germany leads the retail clinic market. Over the coming ten years, the demand for retail clinics in Germany is expected to rise at a 10.6% CAGR.
The Japanese retail clinics market is anticipated to register a CAGR of 10.3% through 2034.
Over the coming ten years, the market in France is expected to rise at a 10.2% CAGR through 2034.
The global retail clinic market is highly fragmented, with key players such as Kroger Co., CVS Health, Rite Aid Corp, Walmart Inc., Walgreens Co., and Nextcare Holdings, Inc. dominating the landscape.
By embedding healthcare services within retail settings, these companies have contributed significantly to the ongoing transformation of healthcare delivery, making essential services more accessible, affordable, and patient-centric for a broader population. Through their strategic location within retail settings, these companies have made accessing healthcare services more convenient, especially for those living in underserved areas. They have also reduced the cost of healthcare services, making them more affordable for the general public.
Recent Developments
The retail clinic market is expected to be worth US$ 5,659.2 million in 2024.
The market for retail clinics is expected to reach US$ 12,308.7 million by 2034.
The retail clinic market is expected to grow at a CAGR of 8.1% from 2024 to 2034.
Some key players in the market are Kroger Co., CVS Health, Rite Aid Corp, Walmart Inc., Walgreens Co., and Nextcare Holdings, Inc.
The drug store segment dominates the market, with a 52.0% share in 2024.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Application, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2024 to 2034 5.3.1. Point-of-Care Diagnostics 5.3.2. Clinical Chemistry & Immunoassays 5.3.3. Vaccinations 5.3.4. Others 5.4. Y-o-Y Growth Trend Analysis By Application, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Application, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2024 to 2034 6.3.1. Retail Pharmacy Settings 6.3.2. Drug Stores 6.3.3. Grocery Chains & Big Box Stores 6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Ownership Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Ownership Type , 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Ownership Type , 2024 to 2034 7.3.1. Hospital-owned Retail Clinics 7.3.2. Retail-owned Retail Clinics 7.4. Y-o-Y Growth Trend Analysis By Ownership Type , 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Ownership Type , 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Application 9.2.3. By Distribution Channel 9.2.4. By Ownership Type 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Application 9.3.3. By Distribution Channel 9.3.4. By Ownership Type 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Application 10.2.3. By Distribution Channel 10.2.4. By Ownership Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Application 10.3.3. By Distribution Channel 10.3.4. By Ownership Type 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Application 11.2.3. By Distribution Channel 11.2.4. By Ownership Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Application 11.3.3. By Distribution Channel 11.3.4. By Ownership Type 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Application 12.2.3. By Distribution Channel 12.2.4. By Ownership Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Application 12.3.3. By Distribution Channel 12.3.4. By Ownership Type 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Application 13.2.3. By Distribution Channel 13.2.4. By Ownership Type 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Application 13.3.3. By Distribution Channel 13.3.4. By Ownership Type 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Application 14.2.3. By Distribution Channel 14.2.4. By Ownership Type 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Application 14.3.3. By Distribution Channel 14.3.4. By Ownership Type 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Application 15.2.3. By Distribution Channel 15.2.4. By Ownership Type 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Application 15.3.3. By Distribution Channel 15.3.4. By Ownership Type 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Application 16.1.2.2. By Distribution Channel 16.1.2.3. By Ownership Type 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Application 16.2.2.2. By Distribution Channel 16.2.2.3. By Ownership Type 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Application 16.3.2.2. By Distribution Channel 16.3.2.3. By Ownership Type 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Application 16.4.2.2. By Distribution Channel 16.4.2.3. By Ownership Type 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Application 16.5.2.2. By Distribution Channel 16.5.2.3. By Ownership Type 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Application 16.6.2.2. By Distribution Channel 16.6.2.3. By Ownership Type 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Application 16.7.2.2. By Distribution Channel 16.7.2.3. By Ownership Type 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Application 16.8.2.2. By Distribution Channel 16.8.2.3. By Ownership Type 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Application 16.9.2.2. By Distribution Channel 16.9.2.3. By Ownership Type 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Application 16.10.2.2. By Distribution Channel 16.10.2.3. By Ownership Type 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Application 16.11.2.2. By Distribution Channel 16.11.2.3. By Ownership Type 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Application 16.12.2.2. By Distribution Channel 16.12.2.3. By Ownership Type 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Application 16.13.2.2. By Distribution Channel 16.13.2.3. By Ownership Type 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Application 16.14.2.2. By Distribution Channel 16.14.2.3. By Ownership Type 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Application 16.15.2.2. By Distribution Channel 16.15.2.3. By Ownership Type 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Application 16.16.2.2. By Distribution Channel 16.16.2.3. By Ownership Type 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Application 16.17.2.2. By Distribution Channel 16.17.2.3. By Ownership Type 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Application 16.18.2.2. By Distribution Channel 16.18.2.3. By Ownership Type 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Application 16.19.2.2. By Distribution Channel 16.19.2.3. By Ownership Type 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Application 16.20.2.2. By Distribution Channel 16.20.2.3. By Ownership Type 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Application 16.21.2.2. By Distribution Channel 16.21.2.3. By Ownership Type 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Application 16.22.2.2. By Distribution Channel 16.22.2.3. By Ownership Type 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Application 16.23.2.2. By Distribution Channel 16.23.2.3. By Ownership Type 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Application 17.3.3. By Distribution Channel 17.3.4. By Ownership Type 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Access Health 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. AtlantiCare 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Aurora Quick Care 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Target Brands Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Kroger 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Wellness Express 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Walgreens Boots Alliance 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Target Clinic Medical Associates 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. RediClinic 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Now Medical Centers 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports